The origin of the Reed-Sternberg cell of Hodgkin's disease remained clouded
in mystery for almost a century after its discovery in 1898. The major obs
tacle to its understanding is that, unlike other cancers, the malignant cel
l of Hodgkin's disease is vastly outnumbered by surrounding non-neoplastic
cells at approximately 1000:1. We have devised several strategies to isolat
e Reed-Sternberg T-cells to determine their origin, global gene expression
and, ultimately, their pathogenesis. This has increased the number of genes
known to be expressed in Reed-Sternberg cells by > 100-fold to over 12,000
. Approaches such as density gradients, microdissection, and cell sorting h
elp to enrich Reed-Sternberg cells for genomic DNA analysis. However, singl
e-cell micromanipulation of living Reed-Sternberg cells was required to det
ermine the genome-wide gene expression profile of these cells. Combined ana
lysis of single cells and cell lines revealed the expression of 2666 named
genes. Further analysis with high-density gene expression microarrays has d
emonstrated the expression of approximately 12,000 genes by Reed-Sternberg
cells. The gene expression profile is that of an aberrant germinal center B
-lymphocyte that resists apoptosis through CD40 signaling and NF kappaB act
ivation. Gene expression analysis of Hodgkin's disease is an extreme test c
ase demonstrating the application of high-throughput gene expression studie
s even to individual cells from clinical samples.